Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MBX Biosciences
Biotech
Zenas, MBX, Bicara head to Nasdaq in hot day for biotech IPOs
It’s a busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therapeutics all going public
James Waldron
Sep 13, 2024 5:25am
MBX aims for $136M IPO to take rival to Ascendis into phase 3
Sep 9, 2024 11:59am
MBX files for IPO to take challenger to Ascendis into phase 3
Aug 26, 2024 9:40am
MBX Biosciences, MaaT Pharma and more—Chutes & Ladders
Jun 28, 2024 8:30am
Former BMS R&D chief Vessey jumping to Flagship—Chutes & Ladders
Jul 14, 2023 9:30am
MBX debuts with $35M to bankroll rare endocrine pipeline
Jul 27, 2020 8:00am
